Form 4 · Filed Jun 16, 2026, 08:42 PM UTC
TVTX/Travere Therapeutics, Inc.
Baynes Roy D. — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | M | other | 4,500 | $21 | $96,210 | 46,000 |
| Jun 12, 2026 | S | sell | 4,500 | $50 | $225,000 | 41,500 |
| Jun 12, 2026 | M | other | 4,500 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001680739-26-000014